Bid Solicitation: BD-19-1039-EHS01-EHS01-33855
Header Information
Bid Number: BD-19-1039-EHS01-EHS01-33855 Description: 19LCEHSLUXTURNAREBATERFA: RFA for Supplemental Rebates for Luxturna Submitted for MassHealth Member Bid Opening Date: 04/16/2019 05:00:00 PM
Purchaser: Lucy Colon Organization: Executive Office of Health and Human Services
Department: EHS01 - EOHHS Location: EHS01 - ONE ASHBURTON
Fiscal Year: 19 Type Code: NS - Non-Statewide Solicitation Allow Electronic Quote: Yes
Alternate Id: 19LCEHSLUXTURNAREBATERFA  Required Date: 12/12/2018 Available Date :  12/12/2018 04:00:00 PM
Info Contact: Lou DeLena, 1 Ashburton Place , 11th Floor, Boston, MA 02108 Phone: 617-573-1686. Email: Louis.DeLena@state.ma.us Bid Type: OPEN Informal Bid Flag: No
Purchase Method: Open Market
Pre Bid Conference:
Bulletin Desc: EOHHS is issuing this Request for Applications ("RFA") to the manufacturer(s) of gene therapy for treatment of patients with confirmed biallelic RPE65 mutation associated retinal dystrophy, specifically the drug Luxturna (voretigene neparvovec-rzyl), for supplemental drug rebates on 1) claims for the manufacturer's drug submitted to MassHealth on a fee-for-service basis; and 2) claims for the manufacturer's drug paid through participating MassHealth managed care entities.
Ship-to Address: Lou Delena
One Ashburton Place, 11th Fl.
Boston, MA 02108
US
Email: Louis.Delena@state.ma.us
Phone: (617)573-1686
Bill-to Address: Arlinda Cardosa
Accounts Payable Unit
600 Washington Street, 7th Fl.
Boston, MA 02111
US
Email: Arlinda.Cardosa@state.ma.us
Phone: (617)210-5073
FAX: (617)210-5468
Print Format:
File Attachments: RFA for Supplemental Rebates for Luxturna
Amendment 1 to the RFA Luxturna
Amendmet #2 to the RFA for Supplemental Drug Rebate Agreement.
Form Attachments:
SBPP (Small Business Purchasing Program) Eligible?: NO
See SBPP requirements and exceptions at www.mass.gov/sbpp :
Amendments:
Amendment # Amendment Date Amendment Note
1 12/20/2018 11:43:58 AM RFA for Supplemental Rebates for Luxturna and changed the Bid Opening date to January 18, 2019 at 5:00 PM. Header 1. Bid Opening Date changed from "12/21/2018 05:00:00 PM" to "01/18/2019 05:00:00 PM". Attachment File Changes: Header 1. File 'RFA for Supplemental Rebates for Luxturna': File 'RFA for Supplemental Rebates for Luxturna' added . Enrollment Date Changes:
2 12/20/2018 03:25:51 PM changed the file name to Amendment 1 to the RFA Luxturna Attachment File Changes: Header 1. File 'Amendment 1 to the RFA Luxturna': File 'Amendment 1 to the RFA Luxturna' added . 2. File 'RFA for Supplemental Rebates for Luxturna': Show Attachment to Vendor Flag changed from "Yes" to "No". Enrollment Date Changes:
3 12/20/2018 03:27:26 PM Attachment File Changes: Header 1. File 'RFA for Supplemental Rebates for Luxturna': File 'RFA for Supplemental Rebates for Luxturna' deleted . Enrollment Date Changes:
4 03/18/2019 11:32:34 AM Posting Amendment #2 to the RFA. Attachment File Changes: Header 1. File 'Amendmet #2 to the RFA for Supplemental Drug Rebate Agreement.': File 'Amendmet #2 to the RFA for Supplemental Drug Rebate Agreement.' added . Enrollment Date Changes:
5 03/18/2019 11:50:48 AM changed the bid Opening date to April 16, 2019 at 5:00 PM. Header 1. Bid Opening Date changed from "01/18/2019 05:00:00 PM" to "04/16/2019 05:00:00 PM". Enrollment Date Changes:
Item Information
Item # 1:   ( 51-21  -  00 )   EOHHS is issuing this Request for Applications ("RFA") to the manufacturer(s) of gene therapy for treatment of patients with confirmed biallelic RPE65 mutation associated retinal dystrophy, specifically the drug Luxturna (voretigene neparvovec-rzyl), for supplemental drug rebates on 1) claims manufacturer's drug submitted to MassHealth on a fee-for-service basis; and 2) claims for manufacturer's drug paid through participating MassHealth managed care entities.
U N S P S C Code: 51-21-00
   Miscellaneous drug categories
Qty Unit Cost UOM Total Discount Amt. Tax Rate Tax Amount Total Cost
1.0   EA - Each        
Manufacturer: Brand: Model:
Make: Packaging:
 
MA-PAS1